Discontinued — last reported Q1 '18
Fair Isaac Allowance for Doubtful Accounts Receivable (Current) increased by 3.1% to $7.72M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 2.9%, from $7.51M to $7.72M. Over 5 years (FY 2020 to FY 2025), Allowance for Doubtful Accounts Receivable (Current) shows an upward trend with a 9.4% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
A significant increase relative to receivables may signal deteriorating customer credit quality or economic headwinds in specific markets.
This is a contra-asset account representing the estimated amount of accounts receivable that the company expects will no...
Standard across all industries; peers in the medical device sector typically maintain low levels unless operating in high-risk emerging markets.
allowance_for_doubtful_accounts_receivable_current| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.51M | $4.15M | $4.28M | $3.78M | $4.01M | $4.22M | $4.22M | $4.59M | $4.94M | $4.98M | $5.41M | $5.81M | $6.19M | $6.45M | $6.94M | $7.51M | $8.04M | $7.96M | $7.49M | $7.72M |
| QoQ Change | — | -7.8% | +3.1% | -11.7% | +6.1% | +5.1% | +0.0% | +8.8% | +7.6% | +0.7% | +8.6% | +7.4% | +6.6% | +4.3% | +7.6% | +8.1% | +7.1% | -0.9% | -6.0% | +3.1% |
| YoY Change | — | — | — | — | -10.9% | +1.5% | -1.5% | +21.4% | +23.2% | +18.0% | +28.2% | +26.5% | +25.2% | +29.7% | +28.4% | +29.3% | +29.9% | +23.4% | +7.9% | +2.9% |